As of 2024-12-12, the Relative Valuation of ACADIA Pharmaceuticals Inc (ACAD) is 17.98 USD. This relative valuation is based on P/E multiples. With the latest stock price at 18.02 USD, the upside of ACADIA Pharmaceuticals Inc based on Relative Valuation is -0.2%.
The range of the Relative Valuation is 16.23 - 21.45 USD.
| Range | Selected | |
| Trailing P/E multiples | 21.0x - 24.8x | 22.5x |
| Forward P/E multiples | 22.7x - 27.8x | 24.0x |
| Fair Price | 16.23 - 21.45 | 17.98 |
| Upside | -9.9% - 19.1% | -0.2% |
| Date | P/E |
| 2024-12-11 | 23.33 |
| 2024-12-10 | 23.99 |
| 2024-12-09 | 24.29 |
| 2024-12-06 | 22.37 |
| 2024-12-05 | 21.64 |
| 2024-12-04 | 22.23 |
| 2024-12-03 | 21.11 |
| 2024-12-02 | 21.51 |
| 2024-11-29 | 21.13 |
| 2024-11-27 | 21.09 |
| 2024-11-26 | 20.99 |
| 2024-11-25 | 21.42 |
| 2024-11-22 | 21.20 |
| 2024-11-21 | 20.95 |
| 2024-11-20 | 21.07 |
| 2024-11-19 | 20.99 |
| 2024-11-18 | 22.05 |
| 2024-11-15 | 21.71 |
| 2024-11-14 | 22.04 |
| 2024-11-13 | 22.78 |
| 2024-11-12 | 23.22 |
| 2024-11-11 | 23.66 |
| 2024-11-08 | 22.87 |
| 2024-11-07 | 22.27 |
| 2024-11-06 | 20.44 |
| 2024-11-05 | 19.42 |
| 2024-11-04 | 18.93 |
| 2024-11-01 | 19.18 |
| 2024-10-31 | 18.89 |
| 2024-10-30 | 19.12 |
| 2024-10-29 | 19.09 |
| 2024-10-28 | 19.09 |
| 2024-10-25 | 18.57 |
| 2024-10-24 | 18.75 |
| 2024-10-23 | 18.50 |
| 2024-10-22 | 18.80 |
| 2024-10-21 | 19.11 |
| 2024-10-18 | 19.81 |
| 2024-10-17 | 19.64 |
| 2024-10-16 | 19.47 |
| 2024-10-15 | 19.31 |
| 2024-10-14 | 19.41 |
| 2024-10-11 | 19.32 |
| 2024-10-10 | 18.84 |
| 2024-10-09 | 18.89 |
| 2024-10-08 | 18.72 |
| 2024-10-07 | 19.07 |
| 2024-10-04 | 19.55 |
| 2024-10-03 | 19.06 |
| 2024-10-02 | 19.59 |